ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VDN Vindon H.

13.25
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vindon H. LSE:VDN London Ordinary Share GB00B06N4S86 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 13.25 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vindon Healthcare Share Discussion Threads

Showing 326 to 350 of 375 messages
Chat Pages: 15  14  13  12  11  10  9  8  7  6  5  4  Older
DateSubjectAuthorDiscuss
08/8/2013
07:31
Are you happy thus far Piedro ?

If the sale goes through will you start a new thread ?

I will be supportive ... but only post say once/twice a month

buywell2
05/8/2013
17:32
Vindon Staff and Directors pose with 'Marilyn Monroe' at the Vindon California Grand Opening Event
piedro
23/7/2013
12:14
VDN California website now available
piedro
17/7/2013
12:01
You could do worse .... but check out Cyprotex (CRX) while you are at it
buywell2
16/7/2013
21:06
Or should we simply reinvest the cash in SBS?
eburne1960
16/7/2013
18:40
Very disappointing here, as a long term holder. However the outsourcing business is exceedingly tough at the moment, and taking a small loss for cash may not be so bad. Once the directors are committed it seems the die is cast.
bonzo
16/7/2013
13:26
Let us see what transpires Piedro

Perhaps you can take over and create one yourself

buywell2
16/7/2013
13:22
buywell2,

Thank you.

This certainly seems a good deal for Source BioScience
but as a shareholder of VDN I feel disappointed - cash
13.70p and shut up !!!
Not even a share offer.

Re: the SBS bb, perhaps you could start a new one as
that available is not very pleasant.

piedro
16/7/2013
09:55
You have been ploughing a lone furrow for many years Piedro

Your hard work has not gone unnoticed

Welcome to the SBS fold

My take is that with SBS using VDN storage facilities in the USA , and Ireland to sell SBS Life Sciences products , antibodies/clones/re-agents from their unique GenomeCube platform which is being rolled out worldwide using different language versions .... Japanese and Korean plus English thus far
www.sourcebioscience.com/our-portfolio/distributors.aspx

Also SBS have been expanding their DNA sequencing services at a pace , profits up circa 50% from this year on year .... they can now do the same from the two USA VDN bases and thus tap into the BIGGEST Pharma Biotech CRO area in the WORLD.


Plus cross selling opportunities to each others Client Lists means the 'Collective' after assimilation should be more than the sum of each of the individuals within 12 months.

Vindon will be the 5th SBS acquisition ..... Turnover for the first 6 months announced next month should be UP 30%. They are going places ..... check out the recent Institutional holdings taken in the company in the last 12 to 18 months. Some BIG names have bought in

Major Shareholders holding over 3% ... Shares in issue :203.8m 2p Ords
Name ........................ Amount ......... % Holding

TD Direct Investing (Europe) 21,000,000 ....10.0
Henderson Global Investors .. 12,095,215 ..... 5.9
Mr S Varkey .................. 3,522,581 ..... 1.73
Seren Capital Manag't ....... 10,675,000 ..... 6.6
SBS Directors/Snr Manag't ....14,222,897 ..... 7.38
Killik & Co LLP ............. 10,586,131 ..... 5.20
Blackrock Inv't Manag't ..... 10,715,000 ..... 5.26
Legal & Gen Assurance ....... 16,637,876 ..... 8.16
Barclays Bank Plc (Pvte Bing) 9,300,000 ...... 4.2
Standard Life Investments .... 9,500,000 ..... 4.66
Mr Yeung Yu Loong ........... 8,528,228 ...... 4.16
Swedbank Robur .............. 6,000,000 ...... 2.94
Talos Securities Ltd. ....... 5,900,000 ...... 2.9%

69%
Per cent of shares
held by top holders





Source BioScience makes a strong start to the year

12 June 2013 | 14:47pm

StockMarketWire.com - Source BioScience, which reported further growth and increased profitability in 2012, has made a good start to this year.

Laurie Turnbull, chairman, told today's AGM: "Demand from the NHS for our diagnostic services continues to be strong and year to date revenue has increased by over 35% compared with the same period last year.

"We remain one of only a small number of accredited laboratories in Europe with access to the technologies and expertise required to deliver complex gene-based diagnostic testing for cancer and other diseases, which affords us commercial advantage."

Mr Turnbull also commented that the company enjoyed a leading position in the UK for the provision of DNA sequencing services and remain the only company offering a UK-based sequencing service.

He added: "This part of our business will be boosted by the expansion of our service into Scotland, enabling us to offer our overnight service for DNA sequencing to the local research community.





Hope this sits well Bro

buywell2
15/7/2013
21:19
eburne1960,

We've been sold out by the board. I presume they'll be keeping
their jobs.

IMO
- Indicates that the directors have been incapable of creating
new partnerships or products - a takeover is their only option

piedro
15/7/2013
20:00
Well well well, possible offer! What do you reckon Piedro? Personally, I'll make a small loss, but it's a decent premium and the shares have gone nowhere for a long time, so I think I'll take it and move on.
eburne1960
11/7/2013
11:06
Vindon at their Santa Fe Springs site are offering ...

Thermal shock chambers for 3 stage thermal cycling


No further information as yet.

piedro
05/7/2013
14:03
ADVFN discriminatory campaign continues

in the URL change 'hxxp' to 'http'

piedro
05/7/2013
13:58
... your invitation



hxxp://www.vindoncalifornia.com

piedro
04/7/2013
16:51
Seemingly desperate for new products ...

June 9, 2013
Integral Finance supported Vindon (Scientific) with work to strengthen it's new product pipeline.
A sector specialist in the storage of pharmaceutical compounds under a range of tightly controlled environmental conditions, Vindon worked with Integral Finance to search for promising emergent technology, augment it's own life science expertise and help further it's growth plans.
"This technology search was undertaken very professionally, and we now have several interesting new opportunities that we are exploring further." Patrick Jackson, Director Vindon Scientific Plc.
hxxp://www.integralfinance.org.uk/wordpress/grow-your-business-virtual-FD-partner/life-science-finance/case-study-3-vindon-scientific

piedro
04/7/2013
12:42
New Vindon storage suite opens at Santa Fe Springs
SANTA FE SPRINGS, Calif. --
The latest controlled environment storage technology will soon be available for the Pharma and Biopharma industries when international storage specialists Vindon Scientific open their new facilities in California. The advanced storage suite will provide a unique service in California to major Pharmaceutical and Biopharma companies, CROs and CMOs that need GMP compliant controlled environment storage.
....
....
Planning for the opening is well underway, with Marilyn Monroe look-alike Jodi Fleischer scheduled to perform the opening ceremony and cut the ribbon. The iconic 'Marilyn' will pose for photos with guests, so it really will be an occasion to remember. ....
hxxp://www.fortmilltimes.com/2013/06/27/2788732/new-vindon-storage-suite-opens.html

piedro
25/6/2013
06:38
Spotlight on Hackett Biologics

24th May 2013
....
Clinical trials using stem cell therapies for spinal cord injury, age-related macular degeneration, Crohn's disease, cardiovascular disease, critical limb ischemia, and multiple sclerosis have recently been publicised, but unless these stem cells can be stabilised the cell technologies can never achieve their full potential and become mainstream treatments. This means that companies will be seeking a storage and transport stabilisation product, as well as a product that can be administered into the body – stabilisation all the way from manufacture to bedside - something that Hackett Biologics' technology can provide. ....
hxxps://www.univercellmarket.com/;news;item/3/123/t/Spotlight+on+Hackett+Biologics/

piedro
13/6/2013
14:48
Work has continued on schedule and the controlled environment rooms are now installed and undergoing their internal fit out.
Electrics are still being installed as well as the back up generator, essential to the secure continuous running of the storage suite. Before long the rooms will be undergo their validation in time for the suite to be operational well before the grand opening on 31st July 2013

piedro
13/6/2013
14:37
... apologies for the state of the header - till ADVFN is
back to normal.

piedro
13/6/2013
14:32
Vindon's California storage facility


Grand Opening Date Set »
31st July 2013 has been set as the date for the grand opening of Vindon's California Storage suite. It will be an interesting day, with the ribbon cutting performed by a special guest. Drinks and hors d'oeuvres will be available for guests and there will be an opportunity to meet Vindon's Director and Staff as well Vindon's partners who help make the facilities service offer complete.

piedro
12/6/2013
11:09
Vindon advertising ...


from
hxxp://www.iptonline.com/articles/public/IPT_29_p72non%20print.pdf

piedro
03/6/2013
16:54
Why?
choose Vindon

http://www.slideshare.net/slideshow/embed_code/22385613

piedro
09/5/2013
15:56
Vindon Healthcare diversifies to support start-ups
Last updated: 2nd Apr 2013 at 09:07am
....
Ferguson told Insider the company had already started working with the University of Manchester and institutions in Leeds and Bristol.
"We are looking at setting up an incubator unit in the UK and using our knowledge to cultivate and nurture fledgling businesses such as university spin outs," he said.
"We recently appointed somebody internally to do that job specifically and have already got two or three interesting opportunities.
"It's a simple fact that many biotech businesses come from universities and we feel we're in as good a position as anybody to invest in these sort of organisations, and for them to see us as a worthwhile investor. ...
"But we're not just investing money, we're investing knowledge as well."

piedro
07/5/2013
11:10
Article by Patrick Jackson

Business Partnering – The Way Forward for Cryogenics

piedro
03/5/2013
13:55
pp-05

Vindon's California facility will provide the same ICH and custom storage services as the Atlanta facility, whilst also providing storage of controlled substances with our partner contract research organisations. Approximately 40 per cent of all public biotech companies in the nation are in California. The state is also home to more than 40 per cent of all employment in the sector and nearly half of all research and development spending in the sector occurs in California.

piedro
Chat Pages: 15  14  13  12  11  10  9  8  7  6  5  4  Older

Your Recent History

Delayed Upgrade Clock